Cite
HARVARD Citation
Vargas, H. et al. (2021). Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective. Clinical pharmacology & therapeutics. 109 (2), pp. 310-318. [Online].